BBM Announces Offer to Acquire YM BioSciences Inc.
obtain additional financing required to achieve ourbusiness goals our technology becoming obsolete changes in businessconditions and the economy and other risk factors identified in theCompany's Form 10-KSB and subsequent reports filed with the Securities andExchange Commission. The Company undertakes no obligation to update theseforward-looking statements for revisions or changes after the
Date:11/13/2008